U.S. Pharmacist Weekly News Update
November 27, 2019

Do Patients ‘Age Out’
With Anticoagulant Use
for Atrial Fibrillation?

Treating atrial fibrillation with anticoagulants in patients in their late 80s or 90s might not be optimal, a new study found. Find out why warfarin wasn’t beneficial after age 87 years and apixaban lost benefit after age 92 years in a model involving nearly 15,000 patients.


How Much Drug Combos
Upped Elderly Fracture Risk
Surprised Researchers

Some common medications, including types of painkillers, diuretics, antidepressants, sleep aids and proton-pump inhibitors, can increase falls, weaken bones, or both, according to a new study. What surprised researchers was how dramatically fracture risk shot up when more than one of those drugs was used. Here are more details.

Direct-Acting Antivirals Highly Effective in Older Patients
With HCVs

With older treatments for hepatitis C (HCV), patients aged 65 years and older were considered to be both poor responders and difficult to treat. As a result, that cohort tended to be undertreated. Find out why a new study insists that older HCV patients respond just as well as younger ones to newer options, i.e., direct-acting antivirals, and should receive the same therapies as everyone else..

Australian Study Finds No Link Between Statins, Memory Loss
Pharmacists field questions all of the time about whether statins really are safe to take. Many of those concerns are about purported memory loss related to the cholesterol-lowering drugs. A new Australian study finds no link between statins and memory loss, however. Here is more information.


Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App